Table 3 Determinants of Mortality among the studied Cohort
Alive (n = 1541, 83%) | Dead (n = 312, 17%) | P-value | |
|---|---|---|---|
Age/years (Median, IQR) | 55 (30) | 73.5 (19) | < 0.001* |
Gender (Male/Female) | 849/692 | 196/116 | 0.012** |
Status (Critical) | 87 (5.6%) | 261 (83.9%) | < 0.001** |
Comorbidity | |||
Hypertension | 174 (11.3%) | 58 (18.5%) | 0.021** |
Cardiovascular Disease | 257 (16.7%) | 92 (29.5%) | < 0.001** |
Chronic Respiratory Disease | 87 (5.6%) | 29 (9.3%) | 0.015** |
Chronic Renal Disease | 143 (9.3%) | 56 (17.9%) | < 0.001** |
Chronic Liver Disease | 27 (1.8%) | 5 (1.6%) | 0.853** |
Dementia | 32 (2.1%) | 13 (4.2%) | 0.029** |
Chronic Neurological Disease | 103 (6.7%) | 43 (13.8%) | < 0.001** |
Connective Tissue Disease | 24 (1.6%) | 6 (1.9%) | 0.641** |
Diabetes Mellitus | 699 (45.4%) | 200 (64.1%) | < 0.001** |
HIV/AIDS | 1 (0.1%) | 0 (0%) | 0.832*** |
Malignancy | 25 (1.6%) | 14 (4.5%) | 0.001** |
Comorbidities | |||
Yes | 870 (56.4%) | 248 (79.5%) | < 0.001*** |
No | 671 (43.5%) | 64 (20.5%) | |
No. of comorbidities | < 0.001** | ||
0 | 671 (43.5%) | 64 (20.5%) | |
1 | 482 (31.3%) | 96 (30.7%) | |
≥ 2 | 388 (25.2%) | 152 (48.7%) | |
4 C Score | < 0.001** | ||
0–3 | 314 (20.4%) | 2 (0.6%) | |
4–8 | 577 (37.4%) | 61 (19.6%) | |
9–14 | 613 (39.8%) | 201 (64.4%) | |
> 15 | 37 (2.4%) | 48 (15.4%) | |